Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Message from EMA’s outgoing Executive Director, Guido Rasi 13 Listopad 2020 News Corporate COVID-19 Ulipristal acetate for uterine fibroids: EMA recommends restricting use 13 Listopad 2020 News Human Referrals Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-5 November 2020 6 Listopad 2020 News Veterinary Medicines Vaccines International regulators and WHO join forces to address COVID-19 challenges 6 Listopad 2020 News Human COVID-19 Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 Listopad 2020 News Human Fees Pharmacovigilance Extra transparency measures for COVID-19 vaccines and therapeutics 30 Říjen 2020 News Human COVID-19 Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 October 2020 30 Říjen 2020 News Human Pharmacovigilance Referrals Regulatory update - EMA encourages companies to submit type I variations for 2020 by end of November 29 Říjen 2020 News Human Veterinary Regulatory and procedural guidance EMA closed 2 November 2020 29 Říjen 2020 News Corporate COVID-19 Strengthening global collaboration on COVID-19 real-world evidence and observational studies 23 Říjen 2020 News Human COVID-19 1 … 73 74 75 76 77 Page 77 of 380 78 79 80 81 … 380
Ulipristal acetate for uterine fibroids: EMA recommends restricting use 13 Listopad 2020 News Human Referrals
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-5 November 2020 6 Listopad 2020 News Veterinary Medicines Vaccines
International regulators and WHO join forces to address COVID-19 challenges 6 Listopad 2020 News Human COVID-19
Regulatory information – 1.7% and 1.6% increase of pharmacovigilance fees from 1 November 2020 4 Listopad 2020 News Human Fees Pharmacovigilance
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 October 2020 30 Říjen 2020 News Human Pharmacovigilance Referrals
Regulatory update - EMA encourages companies to submit type I variations for 2020 by end of November 29 Říjen 2020 News Human Veterinary Regulatory and procedural guidance
Strengthening global collaboration on COVID-19 real-world evidence and observational studies 23 Říjen 2020 News Human COVID-19